Description: Founded by Dr. Jonathan Rothberg in 2013, Quantum-Si is focused on revolutionizing the growing field of proteomics. The company’s suite of technologies are powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing.
Home Page: www.quantum-si.com
QSI Technical Analysis
530 Old Whitfield Street
Guilford,
CT
06437
United States
Phone:
203 458 7100
Officers
| Name | Title |
|---|---|
| Dr. Jonathan M. Rothberg Ph.D. | Founder & Exec. Chairman |
| Ms. Claudia Napal Drayton | Chief Financial Officer |
| Dr. Christian Lapointe J.D., Ph.D. | Gen. Counsel & Corp. Sec. |
| Dr. Michael P. McKenna Ph.D. | Exec. VP of Product Devel. & Operations |
| Mr. Jeffrey Alan Hawkins | CEO & Director |
| Dr. Patrick Schneider Ph.D. | Pres & COO |
| Mr. Todd Rearick | Chief Technology Officer |
| Mr. Juan Esteban Avendano | VP of Investor Relations |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 3.1774 |
| Price-to-Book MRQ: | 0.8083 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2021-06-10 |
| Fiscal Year End: | December |
| Full Time Employees: | 153 |